You have 0 free articles left this month.
Register for a free account to access unlimited free content.

Lawyers Weekly - legal news for Australian lawyers

Powered by MOMENTUM MEDIA
lawyers weekly logo

Powered by MOMENTUM MEDIA

Advertisement
Goodbye job applications, hello dream career
Seize control of your career and design the future you deserve with LW career

Bakers and Clutz advise on pharmaceutical offload

Baker & McKenzie and Clayton Utz advise on the sale of Australian-based iNova Pharmaceuticals to Canada-based Valeant Pharmaceuticals.

user iconDigital 11 January 2012 Big Law
Bakers and Clutz advise on pharmaceutical offload
expand image

Firms: Baker & McKenzie (Valeant Pharmaceuticals); Clayton Utz (Ironbridge and Archer Capital)

 
 

Deal: NYSE-listed, Canada-based Valeant Pharmaceuticals acquisition of Australian-based iNova Pharmaceuticals from Ironbridge and Archer Capital. Deal officially closed on 21 December

Area: M&A

Value: $625 million upfront and up to an additional $75 million in potential milestones 

Key players: The Bakers team was led by Sydney-based partner David Egan and associate Michael Dearden

Tags
You need to be a member to post comments. Become a member for free today!